Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.54 |
| ▸ | EGFR | P00533 | 12/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
| ▸ | TDO2 | P48775 | 1/20 | 0.43 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.42 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31514609 | 0.93 | HTR2A (0.50) | CNR2EGFRTDO2AURKBMAP4K4 | |
| SCHEMBL31514623 | 0.90 | CNR2 (0.52) | CNR2EGFRTDO2AURKBMAP4K4 | |
| SCHEMBL31514625 | 0.87 | TDO2 (0.48) | CNR2EGFRTDO2MAP4K4HTR2A | |
| SCHEMBL31514592 | 0.87 | TDO2 (0.48) | CNR2EGFRTDO2MAP4K4HTR2A | |
| SCHEMBL31514581 | 0.85 | EGFR (0.54) | CNR2EGFRAURKBMAP4K4 | |
| SCHEMBL31514589 | 0.85 | CNR2 (0.54) | CNR2EGFRKCNH2AURKBMAP4K4 | |
| SCHEMBL31514562 | 0.85 | CNR2 (0.47) | CNR2EGFRMAP4K4 | |
| SCHEMBL31514585 | 0.84 | CD38 (0.48) | CNR2EGFRAURKB | |
| SCHEMBL31514567 | 0.83 | EGFR (0.49) | CNR2EGFRTDO2AURKBMAP4K4 | |
| SCHEMBL31514606 | 0.83 | CD38 (0.47) | CNR2EGFRAURKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119912429-A | Quinazoline compound with anti-inflammatory activity or pharmaceutically acceptable salt thereof, pharmaceutical composition and application thereof | 安徽医科大学 | 2025-05-02 | — | — | CN | disclosed |